Sigma Aldrich (10,200)

Lead in Powdered Paint

EPINEPHRINE-13C6 HCL

MF: None / MW: None

D-(+)-GLUCURONIC ACID

MF: None / MW: None

Estrone-2,3,4-¹³C₃ solution

5-Aminolevulinic acid-¹³C₅, ¹⁵N hydrochloride

99 atom % ¹³C, 98 atom % ¹⁵N, 97% (CP)MF: ¹³C₅H₁₀Cl¹⁵NO₃ / MW: 173.55

Lithocholic-2,2,4,4-d₄ acid 3-sulfate disodium salt

≥98 atom % D, ≥98% (CP)MF: C₂₄D₄H₃₄Na₂O₆S / MW: 504.62

Ethylbenzene solution

suitable for NMR (reference standard), 10% in chloroform-d (99.8 atom % D), NMR tube size 10 mm × 8 in.CAS No: 100-41-4 / MF: C₈H₁₀ / MW: 106.17

Iodomethane-¹²C,d₃

99.9 atom % ¹²C, 98 atom % D, 99% (CP), contains copper as stabilizerCAS No: 865-50-9 / MF: ¹²CD₃I / MW: 144.95

Diethyl (phenylsulfinylmethyl-¹³C)phosphonate

99 atom % ¹³CMF: ¹³CC₁₀H₁₇O₄PS / MW: 277.28

Clodinafop-propargyl-(phenoxy-¹³C₆)

≥98 atom % ¹³C, ≥98% (CP)MF: ¹³C₆C₁₁H₁₃ClFNO₄ / MW: 355.70

SLAM-Vᵖʳᵒᴿ-¹³CH₃ Methyl Labeling Kit

Deoxycholic-2,2,4,4-d₄ acid 3-sulfate disodium salt

≥98 atom % D, ≥98% (CP)MF: C₂₄D₄H₃₄O₇SNa₂ / MW: 520.62

Taurolithocholic-2,2,4,4-d₄ acid 3-sulfate disodium salt

≥98 atom % D, ≥98% (CP)MF: C₂₆D₄H₃₉NO₈S₂Na₂ / MW: 611.76

Formic acid-¹³C

95 wt. % in H₂O, 99 atom % ¹³CCAS No: 1633-56-3 / MF: ¹³CH₂O₂ / MW: 47.02

Diethyl (phenylsulfonylmethyl-¹³C)phosphonate

99 atom % ¹³CCAS No: 1190788-54-5 / MF: ¹³CC₁₀H₁₇O₅PS / MW: 293.28

Sulfur-³²S

99.9 atom % ³²SCAS No: 13981-57-2 / MF: ³²S / MW: 31.97

Propionitrile-d₅

99 atom % DCAS No: 10419-75-7 / MF: C₃D₅N / MW: 60.11

2-Keto-3-(methyl-d₃)-butyric acid-4-¹³C,3-d sodium salt

99 atom % ¹³C, 97 atom % D, 97% (CP)MF: ¹³CC₄H₃D₄NaO₃ / MW: 143.11

Cortisone-2,3,4-¹³C₃ 21-sulfate sodium salt solution

100 μg/mL in methanol, ≥98 atom % ¹³C, ≥95% (CP)MF: ¹³C₃C₁₈H₂₇NaO₈S / MW: 465.47

DLAM-LVᵖʳᵒᴿ-¹³CH₃ Methyl Labeling Kit

4-Fluorobenzoic acid-α-¹³C-2,3,5,6-d₄

99 atom % ¹³C, 98 atom % DCAS No: 285977-82-4 / MF: ¹³CC₆D₄HFO₂ / MW: 145.13

Triphenylphosphine-d₁₅

≥98 atom % D, 99% (CP)CAS No: 24762-44-5 / MF: C₁₈D₁₅P / MW: 277.38

DEUTERIUM OXIDE-18O WITH EXTENDED TESTI&

Acetic-¹³C₂,d₄

97 atom % ¹³C, 97 atom % DCAS No: 107745-70-0 / MW: 63.07

Chloroform solution

suitable for NMR (reference standard), 0.3% in acetone-d₆ (99.9 atom % D), NMR tube size 3 mm × 8 in.

L-Lactic acid-3-¹³C

99 atom % ¹³C, 98% (CP), ≥99% (Chiral Purity)CAS No: 155307-62-3 / MF: ¹³CC₂H₆O₃ / MW: 91.07

γ-Muricholic acid-2,2,3,4,4-d₅

≥99 atom % D, ≥98% (CP)MF: C₂₄H₃₅D₅O₅ / MW: 413.60

N-Phenyl-¹³C₆-2-napthylamine

≥98 atom % ¹³C, ≥98% (CP)MF: ¹³C₆C₁₀H₁₃N / MW: 225.24

N-Nitrosodimethylamine-d₆

98 atom % DCAS No: 17829-05-9 / MF: C₂D₆N₂O / MW: 80.12

Stearoyl-¹³C₁₈ coenzyme A lithium salt

99 atom % ¹³C, 95% (CP)MF: ¹³C₁₈C₂₁H₇₀N₇O₁₇P₃S · xLi⁺ / MW: 1051.86 (free acid basis)

Sodium acetate-¹³C₂

endotoxin tested, 99 atom % ¹³CCAS No: 56374-56-2 / MF: ¹³C₂H₃NaO₂ / MW: 84.02

Ursodeoxycholic-2,2,4,4-d₄ acid 3-sulfate disodium salt

≥98 atom % D, ≥98%MF: C₂₄D₄H₃₄Na₂O₇S / MW: 520.62

Acetaminophen-(ring-¹³C₆)

≥98 atom % ¹³C, ≥98% (CP)MF: C₂¹³C₆H₉NO₂ / MW: 157.12

Benzene-¹³C

99 atom % ¹³CCAS No: 6998-50-1 / MF: ¹³CC₅H₆ / MW: 79.10

Cholic-2,2,4,4-d4 acid 3-sulfate disodium salt

≥98 atom % D, ≥98% (CP)MF: C₂₄D₄H₃₄Na₂O₈S / MW: 536.62

Glycochenodeoxycholic-2,2,4,4-d₄ acid 3-sulfate disodium salt

≥98 atom % D, ≥98% (CP)MF: C₂₆D₄H₃₇NO₈SNa₂ / MW: 577.67

N,N-Dimethyl-d₆-formamide

≥98 atom % D, ≥98% (CP)CAS No: 185990-36-7 / MF: C₃D₆HNO / MW: 79.13

Ethyl acetate-2-¹³C

99 atom % ¹³CCAS No: 58735-82-3 / MF: ¹³CC₃H₈O₂ / MW: 89.10

Glycolithocholic-2,2,4,4-d₄ acid solution

100 μg/mL in methanol, ≥98 atom % D, ≥98% (CP)MF: C₂₆D₄H₃₉NO₄ / MW: 437.65

2-Keto-3-(methyl-¹³C,d₁)-butyric-3,4,4,4-d4 acid sodium salt

98 atom % D, 99 atom % ¹³C, 97% (CP)MF: CD₃CD¹³CDH₂COCO₂Na / MW: 144.12

Dimethyl-d₆ disulfide

98 atom % DCAS No: 7282-94-2 / MF: C₂D₆S₂ / MW: 100.24

Potassium nitrate-¹⁵N

98 atom % ¹⁵NCAS No: 57654-83-8 / MF: K¹⁵NO₃ / MW: 102.10

1-Ethyl-3-methylimidazolium chloride-d₁₁

98 atom % DCAS No: 160203-52-1 / MF: C₆D₁₁ClN₂ / MW: 157.69

Vitamin D₃-6,19,19-d₃ sulfate sodium salt solution

100 μg/mL in ethanol, 98 atom % D, 97% (CP)MF: C₂₇D₃H₄₀O₄SNa / MW: 489.70

SLAM-Aβ-¹³CHD₂ Methyl Labeling Kit

Ammonia-d₃

99 atom % DCAS No: 13550-49-7 / MF: D₃N / MW: 20.05

Super Box

Oxygen Cylinder Case

Tetrahydrocortisone-2,2,3,4,4-d₅ solution

100 μg/mL in methanol, ≥98 atom % D, ≥98% (CP)MF: C₂₁D₅H₂₇O₅ / MW: 369.51

Iodomethane-¹³C solution

suitable for NMR (reference standard), 1% in chloroform-d (100%, 99.96 atom % D), chromium (III) acetylacetonate 0.2 %, trimethyl phosphite 1 %, 99 atom % ¹³C, NMR tube size 6.5 mm × 8 in.MF: ¹³CH₃I / MW: 142.93

Vitamin K₂ (MK-9)-4′,5,6,7,8,8′-¹³C₆

≥99 atom % ¹³C, ≥95% (CP)MF: ¹³C₆C₅₀H₈₀O₂ / MW: 791.19

17α-Methyl-5β-androstan-3α,17β-diol-20,20,20-d₃

≥98 atom % D, ≥95% (CP)MF: C₂₀H₃₁D₃O₂ / MW: 309.50

ᴅʟ-Lysine-1,2-¹³C₂ dihydrochloride

99 atom % ¹³CCAS No: 286437-16-9 / MF: ¹³C₂C₄H₁₄N₂O₂ · 2HCl / MW: 221.09

ᴅʟ-Aspartic acid-3-¹³C

99 atom % ¹³CCAS No: 202326-56-5 / MF: ¹³CC₃H₇NO₄ / MW: 134.10

Diethyl 2-phthalimidomalonate-2-¹³C

99 atom % ¹³CCAS No: 92096-47-4 / MF: ¹³C₁₅H₁₅NO₆ / MW: 320.17

Glycocholic-2,2,4,4-d₄ acid 3-sulfate disodium salt

≥98 atom % D, ≥98% (CP)MF: C₂₆D₄H₃₇NNa₂O₉S / MW: 593.67

α-Tocopherol-(trimethyl-¹³C₃ phenyl)

≥99 atom % ¹³C, ≥96% (CP)MF: ¹³C₃C₂₆H₅₀O₂ / MW: 433.68

ᴅ-Glucose-¹³C₆

endotoxin tested, 99 atom % ¹³CCAS No: 110187-42-3 / MF: ¹³C₆H₁₂O₆ / MW: 186.11

Ammonium nitrate-¹⁵N

10 atom % ¹⁵NCAS No: 31432-46-9 / MF: H₄N¹⁵NO₃ / MW: 81.04

Water-¹⁸O

(for PET), ≥98 atom % ¹⁸OCAS No: 14314-42-2 / MF: H₂¹⁸O / MW: 20.02

Iodomethane-¹³C,d₂

≥98 atom % ¹³C, ≥98 atom % D, ≥99% (CP), contains copper as stabilizerCAS No: 207507-22-0 / MF: ¹³CD₂HI / MW: 144.94

1-Bromohexadecane-d₃₃

98 atom % DMF: C₁₆D₃₃Br / MW: 338.54

γ-Butyrolactone-d₆

98 atom % DCAS No: 77568-65-1 / MF: C₄D₆O₂ / MW: 92.13

PLAM-AβIδ1LVProSTγ-¹³CH₃ Methyl Labeling Kit

Glycoursodeoxycholic-2,2,4,4-d₄ acid solution

100 μg/mL in methanol, ≥98 atom % D, ≥97% (CP)MF: C₂₆D₄H₃₉NO₅ / MW: 453.65

ᴅ-Fructose-2-¹³C

99 atom % ¹³CCAS No: 117013-19-1 / MF: ¹³CC₅H₁₂O₆ / MW: 181.15

1,7-Dimethylxanthine-2,4,5,6-¹³C₄-1,3,9-¹⁵N₃

≥98 atom %, ≥98% (CP)CAS No: 1173018-79-5 / MF: ¹³C₄C₃H₈¹⁵N₃NO₂ / MW: 187.11

18-Hydroxycorticosterone-9,11,12,12-d₄

≥98 atom % D, ≥95% (CP)CAS No: 1257742-38-3 / MF: C₂₁D₄H₂₆O₅ / MW: 366.48

Valve

brass bellows, 1/4 in. NPT straight path, external

DLAM-Iδ1Tγ-¹³CH₃ Methyl Labeling Kit

2-Mercaptoethanol-d₆

96 atom % D, 98% (CP)CAS No: 203645-37-8 / MF: C₂D₆OS / MW: 84.17

11-Deoxycortisol-2,3,4-¹³C₃ solution

100 μg/mL in methanol, ≥98 atom % ¹³C, ≥97% (CP)MF: ¹³C₃C₁₈H₃₀O₄ / MW: 349.44

2-Methylglutaric-4,5-¹³C₂ acid solution

1 mg/mL in methanol, ≥98 atom % ¹³C, ≥95% (CP)MF: ¹³C₂C₄H₁₀O₄ / MW: 148.13

Potassium nitrate-¹⁵N

5 atom % ¹⁵NCAS No: 57654-83-8 / MF: K¹⁵NO₃ / MW: 102.10

Pyrex® breakseal flask

capacity 0.5 L

In Vitro Protein Expression (iPE) Kit II

Ethylbenzene solution

suitable for NMR (reference standard), 0.1% in chloroform-d (100%, 99.96 atom % D)CAS No: 100-41-4 / MF: C₈H₁₀ / MW: 106.17

7-Dehydrocholesterol-25,26,26,26,27,27,27-d₇

≥99 atom % D, ≥98% (CP)CAS No: 388622-58-0 / MF: C₂₇D₇H₃₇O / MW: 391.68

Potassium nitrate-¹⁵N

10 atom % ¹⁵NCAS No: 57654-83-8 / MF: K¹⁵NO₃ / MW: 102.10

Adenosine-¹³C₁₀,¹⁵N₅

≥98 atom %, ≥95% (CP)CAS No: 202406-75-5 / MF: ¹³C₁₀H₁₃¹⁵N₅O₄ / MW: 282.13

DLAM-LVproS-¹³CH₃ Methyl Labeling Kit

Toluene-¹³C₇

99 atom % ¹³C, 99% (CP)CAS No: 287399-36-4 / MF: ¹³C₇H₈ / MW: 99.09

DMT-2′O-TBDMS-rU-1,3-¹⁵N₂ phosphoramidite

≥98 atom % ¹⁵N, ≥95% (CP)MF: C₄₅H₆₁¹⁵N₂N₂O₉PSi / MW: 863.03

Ammonia-¹⁵N

98 atom % ¹⁵NCAS No: 13767-16-3 / MF: H₃¹⁵N / MW: 18.02

DMT-2′O-TBDMS-rU-3-¹⁵N phosphoramidite

≥98 atom % ¹⁵N, ≥95% (CP)MF: C₄₅H₆₁¹⁵NN₃O₉PSi / MW: 862.04

Ethylene-d₄ oxide

≥98 atom % D, ≥99% (CP), contains hydroquinone as stabilizerCAS No: 6552-57-4 / MF: C₂D₄O / MW: 48.08

Gadolinium(III) chloride solution

suitable for NMR (reference standard), 0.1 mg/mL in D₂O (99.9 atom % D), water 0.1 %, NMR tube size 6.5 mm × 8 in.CAS No: 10138-52-0 / MF: Cl₃Gd / MW: 263.61

Pyrex® breakseal flask

capacity 0.25 L

Sodium taurochenodeoxycholate-2,2,3,4,4,6,6,7,8-d₉ solution

100 μg/mL in methanol, ≥98 atom % D, ≥98% (CP)MF: C₂₆D₉H₃₅NO₆SNa / MW: 530.74

Ubiquitin-¹⁵N,D human

98 atom % ¹⁵N, 97 atom % D, recombinant, expressed in E. coli

Chenodeoxycholic-2,2,4,4-d₄ acid 3-sulfate disodium salt

≥98 atom % D, ≥98% (CP)MF: C₂₄D₄H₃₄O₇SNa₂ / MW: 520.62

Cytidine-¹³C₉,¹⁵N₃ 5′-monophosphate disodium salt solution

100 mM (in 5mM Tris HCl / H₂O), ≥98 atom %, ≥95% (CP)MW: 379.07

Cholesteryl-25,26,26,26,27,27,27-d7 sulfate sodium salt

≥98 atom % D, ≥98% (CP)MF: C₂₇D₇H₃₈O₄SNa / MW: 495.74

HLAM-AβIδ1MεLVproSTγ-¹³CH₃ Methyl Labeling Kit

Sodium taurochenodeoxycholate-2,2,4,4-d₄

≥98 atom % D, ≥97% (CP)MF: C₂₆D₄H₄₀NNaO₆S / MW: 525.71

DLAM-Iδ1VproS-¹³CH₃ Methyl Labeling Kit

Sodium taurochenodeoxycholate-2,2,3,4,4,6,6,7,8-d₉

≥98 atom % D, ≥98% (CP)MF: C₂₆D₉H₃₅NaNO₆S / MW: 530.74

Glycolithocholic-2,2,4,4-d₄ acid 3-sulfate disodium salt

≥98 atom % D, ≥98% (CP)MF: C₂₆D₄H₃₇NO₇SNa₂ / MW: 561.68

Guanosine-¹³C₁₀,¹⁵N₅ 5′-monophosphate disodium salt solution

100 mM (in 5mM Tris HCl / H₂O), ≥98 atom %, ≥95% (CP)MW: 422.08

ʟ-Malic acid-¹³C₄

≥99 atom % ¹³C, ≥97% (CP)CAS No: 150992-96-4 / MF: ¹³C₄H₆O₅ / MW: 138.06

17β-Estradiol-2,3,4-¹³C₃ 17-undecanoate solution

100 μg/mL in methanol, ≥98 atom % ¹³C, ≥95% (CP)MF: ¹³C₃C₂₆H₄₄O₃ / MW: 443.64